Skip to main content

Advertisement

Log in

Behcet’s disease associated with malignancy in Korea: a single center experience

  • Short Communication
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The aim of this study was to determine the clinical characteristics of Behcet’s disease (BD) complicated with malignancy in Korea. Of 1,769 patients with BD in our hospital, 32 patients (1.8%, 21 in solid cancer, 11 in hematologic malignancy) developed cancer. In 10 of the 32 subjects (31.3%), malignancy was diagnosed before or concomitantly with BD. Twelve cases (37.5%) occurred within the first 2 years of disease and 9 cases (28.1%) occurred 5 years after the diagnosis of BD. Myelodysplastic syndrome (MDS) was the most common disease (n = 7) followed by thyroid cancer (n = 4), breast cancer, cervix cancer, stomach cancer, rectal cancer, hepatoma, aplastic anemia (n = 3, each), renal cell cancer, endometrial cancer, lymphoma (n = 1, each). There were no significant differences in the clinical characteristic between patients with or without malignancy. Intestinal involvement were more frequent in patients with malignancy than those without, but was not statistically significant (p = 0.083). Our results demonstrate that MDS and thyroid cancer are the most common hematologic disease and solid cancer associated with BD, respectively. Further studies will be required to ascertain the pathogenic link between BD and malignancy and the prevalence of malignancy in BD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behcet’s disease. N Engl J Med 341:1284–1291

    Article  CAS  PubMed  Google Scholar 

  2. Abu-Shakra M, Guillemin F, Lee P (1993) Cancer in systemic sclerosis. Arthritis Rheum 36:460–464

    Article  CAS  PubMed  Google Scholar 

  3. Abu-Shakra M, Gladman DD, Urowitz MB (1996) Malignancy in systemic lupus erythematosus. Arthritis Rheum 39:1050–1054

    Article  CAS  PubMed  Google Scholar 

  4. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, Evans SR, Felson DT (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96–100

    Article  CAS  PubMed  Google Scholar 

  5. Pankhurst T, Savage CO, Gordon C, Harper L (2004) Malignancy is increased in ANCA-associated vasculitis. Rheumatology (Oxford) 43:1532–1535

    Article  CAS  Google Scholar 

  6. Cengiz M, Altundag MK, Zorlu AF, Gullu IH, Ozyar E, Atahan IL (2001) Malignancy in Behcet’s disease: a report of 13 cases and a review of the literature. Clin Rheumatol 20:239–244

    Article  CAS  PubMed  Google Scholar 

  7. Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60–76

    Article  Google Scholar 

  8. Kaklamani VG, Tzonou A, Kaklamanis PG (2005) Behcet’s disease associated with malignancies. Report of two cases and review of the literature. Clin Exp Rheumatol 23:S35–S41

    CAS  PubMed  Google Scholar 

  9. Bozi E, Katoulis AC, Stavrianeas NG (2007) Association of Behcet’s disease with hematologic malignancies. Int J Dermatol 46:333–334

    Article  PubMed  Google Scholar 

  10. Criteria for diagnosis of Behcet’s disease (1990) International Study Group for Behcet’s Disease. Lancet 335:1078–1080

    Google Scholar 

  11. Kaklamani VG, Sadim M, Koumantaki Y, Kaklamanis P, Pasche B (2008) Role of polymorphisms in adamantiades—Behcet’s disease. J Rheumatol 35:2376–2378

    Article  PubMed  Google Scholar 

  12. Shin HR, Jung KW, Won YJ, Park JG, 139 KCCR-affiliated Hospitals (2004) 2002 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 139 Hospitals. Cancer Res Treat 36:103–114

    Google Scholar 

  13. Fain O, Hamidou M, Cacoub P, Godeau B, Wechsler B, Paries J, Stirnemann J, Morin AS, Gatfosse M, Hanslik T, Belmatoug N, Bletry O, Cevallos R, Delevaux I, Fisher E, Hayem G, Kaplan G, Le Hello C, Mouthon L, Larroche C, Lemaire V, Piette AM, Piette JC, Ponge T, Puechal X, Rossert J, Sarrot-Reynauld F, Sicard D, Ziza JM, Kahn MF, Guillevin L, Godeau P (2007) Vasculitides associated with malignancies: analysis of sixty patients [Vasculitis and neoplasms. 14 cases]. Arthritis Rheum 57:1473–1480

    Article  PubMed  Google Scholar 

  14. Ahn JK, Cha HS, Koh EM, Kim SH, Kim YG, Lee CK, Yoo B (2008) Behcet’s disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8. Rheumatology (Oxford) 47:1228–1230

    Article  CAS  Google Scholar 

  15. Kawabata H, Sawaki T, Kawanami T, Shimoyama K, Karasawa H, Fukushima T, Masaki Y, Ogawa N, Hirose Y, Ozaki K, Shimanaka K, Takase S, Ueno H, Umehara H (2006) Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8. Int Med 45:1309–1314

    Article  Google Scholar 

Download references

Conflict of interest statement

The authors have declared no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hoon-Suk Cha.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahn, J.K., Oh, J.M., Lee, J. et al. Behcet’s disease associated with malignancy in Korea: a single center experience. Rheumatol Int 30, 831–835 (2010). https://doi.org/10.1007/s00296-009-1319-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-1319-3

Keywords

Navigation